Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Myelodysplastic Syndromes 71Leukemia 68Lymphoma 65Leukemia, Myeloid, Acute 63Leukemia, Lymphocytic, Chronic, B-Cell 61Lymphoma, Non-Hodgkin 56Hodgkin Disease 51Multiple Myeloma 45Leukemia, Myeloid, Chronic-Phase 44Lymphoma, Follicular 43Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 42Leukemia, Myeloid, Accelerated Phase 42Lymphoma, B-Cell, Marginal Zone 41Myeloproliferative Disorders 40Burkitt Lymphoma 40Lymphoma, Large-Cell, Immunoblastic 35Neoplasms, Plasma Cell 34Congenital Abnormalities 31Leukemia, Myelomonocytic, Chronic 29Blast Crisis 29Dendritic Cell Sarcoma, Interdigitating 28Primary Myelofibrosis 26Recurrence 25Lymphoma, T-Cell, Cutaneous 23Anemia, Refractory, with Excess of Blasts 23Myelodysplastic-Myeloproliferative Diseases 22Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 22Graft vs Host Disease 22

Interventions

fludarabine phosphate 7Whole-Body Irradiation 7Cyclophosphamide 7fludarabine 6Mycophenolic Acid 6Tacrolimus 3Peripheral Blood Stem Cell Transplantation 3Sirolimus 2Cyclosporine 2Antilymphocyte Serum 2Allopurinol 2venetoclax 1itacitinib 1carmustine, poliferprosan 20 drug combination 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Etoposide 1Cytarabine 1Cyclosporins 1Carmustine 1Association 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Plasma Cell × Antilymphocyte Serum × Lymphoid × Clear all
NCT02722668 2025-07-04

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
15 enrolled 15 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Plasma Cell, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT02661035 2023-09-21

Allo HSCT Using RIC for Hematological Diseases

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
156 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hematologic Diseases, Leukemia, Plasma Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡